| 2012-06 | Natural History and Epidemiology of Non-alcoholic Fatty Liver Disease in Korea. | 손주현 |
| 2017-08 | New botanical drug, HL tablet, reduces hepatic fat as measured by magnetic resonance spectroscopy in patients with nonalcoholic fatty liver disease: A placebo-controlled, randomized, phase II trial | 손주현 |
| 2019-08 | The New Cutoff Value of the Hepatic Venous Pressure Gradient on Predicting Long-Term Survival in Cirrhotic Patients | 손주현 |
| 2020-11 | No Difference in Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection Treated With Entecavir vs Tenofovir | 손주현 |
| 2014-01 | Nondiseased Liver Stiffness Measured by Shear Wave Elastography A Pilot Study | 손주현 |
| 2016-04 | The Optimal Cut-Off Value of Neutrophil-to-Lymphocyte Ratio for Predicting Prognosis in Adult Patients with Henoch-Schönlein Purpura | 손주현 |
| 2016-03 | Outcomes of Propofol Sedation During Emergency Endoscopy Performed for Upper Gastrointestinal Bleeding | 손주현 |
| 2014-10 | Pentoxifylline vs. corticosteroid to treat severe alcoholic hepatitis: A randomised, non-inferiority, open trial | 손주현 |
| 2014-06 | Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B | 손주현 |
| 2018-12 | Presence of Sarcopenia and Its Rate of Change Are Independently Associated with Long-term Mortality in Patients with Liver Cirrhosis | 손주현 |
| 2012-09 | A Prospective Nationwide Study of Drug-Induced Liver Injury in Korea | 손주현 |
| 2013-10 | Randomized clinical trial: Effects of multi-species probiotics on small intestinal bacterial overgrowth in patients with chronic liver disease- a placebo controlled study | 손주현 |
| 2016-11 | A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis | 손주현 |
| 2013-10 | A Randomized, Multi-center, Phase IV Open-label Study to Evaluate and Compare the Effect of Carvedilol versus Propranolol on Reduction in Portal Pressure in Patients with Cirrhosis: an Interim Analysis | 손주현 |
| 2014-10 | Real time shear wave elastography in chronic liver diseases: Accuracy for predicting liver fibrosis, in comparison with serum markers | 손주현 |
| 2019-03 | Recent research trends and updates on nonalcoholic fatty liver disease | 손주현 |
| 2012-04 | REGRESSION OF HEPATIC FIBROSIS AND STELLATE CELL ACTIVATION BY CAFFEINE IN A CIRRHOTIC RAT MODEL | 손주현 |
| 2014-10 | Relative adrenal insufficiency in chronic liver disease: its prevalence and effects on long-term mortality | 손주현 |
| 2016-05 | Repeated Panniculitis Induced by Pegylated Interferon Alpha 2a in a Patient with Chronic Hepatitis C | 손주현 |
| 2012-03 | Revision and update on clinical practice guideline for Liver cirrhosis. | 손주현 |
| 2017-11 | Role of Shear Wave Elastography in Evaluating the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B | 손주현 |
| 2018-09 | Role of two-dimensional shear wave elastography in chronic liver diseases: A narrative review | 손주현 |
| 2014-09 | Sarcopenia as a Useful Predictor for Long-Term Mortality in Cirrhotic Patients with Ascites | 손주현 |
| 2018-04 | Serum cystatin C level: An excellent predictor of mortality in patients with cirrhotic ascites | 손주현 |
| 2015-03 | Severe Portal Hypertension in Cirrhosis: Evaluation of Perfusion Parameters with Contrast-Enhanced Ultrasonography | 손주현 |
| 2014-12 | Shear-Wave Elastography: A Noninvasive Tool for Monitoring Changing Hepatic Venous Pressure Gradients in Patients with Cirrhosis | 손주현 |
| 2013-04 | SHORT-TERM SURVIVAL IN PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS TREATED WITH PENTOXIFYLLINE vs. CORTICOSTEROID: A NON-INFERIORITY TRIAL - A PRELIMINARY REPORT | 손주현 |
| 2019-02 | Spleen Stiffness Measurement Using 2-Dimensional Shear Wave Elastography: The Predictors of Measurability and the Normal Spleen Stiffness Value | 손주현 |
| 2012-10 | Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B. | 손주현 |
| 2018-03 | Tenofovir disoproxil fumarate monotherapy is superior to entecavir-adefovir combination therapy in patients with suboptimal response to lamivudine-adefovir therapy for nucleoside-resistant HBV: a 96-week prospective multicentre trial | 손주현 |
